Ganga Pharmaceuticals Balance Sheet Annual

BSE: - | NSE: - | ISIN: - | Sector: -

12.00 0.00 (0.00%)Updated : 12 Feb 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Liabilities Shareholders' Equity	9.65	8.97	8.65	7.98
Long Term Debt	0.10	0.23	0.39	0.63
Common Stock Total	5.91	4.84	4.84	4.06
Other Current Assets Total	2.48	1.94	2.05	1.61
Total Assets	9.65	8.97	8.65	7.98
Current Portof LT Debt/ Capital Leases	0.99	0.17	0.21	0.16
Cash	0.06	0.30	0.03	0.03
Total Equity	8.31	7.13	7.05	5.45
Retained Earnings( Accumulated Deficit)	2.40	2.29	2.22	1.39
Total Common Shares Outstanding	0.59	0.48	0.48	0.41
Tangible Book Valueper Share Common Eq	14.06	14.74	14.58	13.42
Total Liabilities	1.34	1.84	1.60	2.53
Total Debt	1.09	1.42	1.36	1.83
Cashand Short Term Investments	0.06	0.30	0.03	0.03
Total Receivables Net	3.86	3.45	2.43	2.33
Deferred Income Tax	0.00	0.01	0.00	0.00
Accounts Receivable- Trade Net	0.94	0.91	0.92	0.89
Property/ Plant/ Equipment Total- Net	0.65	0.66	0.61	0.64
Total Current Liabilities	1.24	1.60	1.20	1.89
Total Inventory	1.17	1.18	1.24	1.18
Accounts Payable	0.12	0.28	0.10	0.58
Other Currentliabilities Total	0.13	0.14	0.13	0.12
Total Long Term Debt	0.10	0.23	0.39	0.63
Other Long Term Assets Total	1.44	1.44	2.20	2.11
Total Current Assets	7.56	6.87	5.75	5.15
period Length	0.00	0.00	0.00	0.00
Other Liabilities Total	-	0.00	0.00	-
Long Term Investments	-	0.00	0.08	0.08
Notes Payable/ Short Term Debt	-	1.01	0.76	1.03